Insulin-like growth factor-I and new opportunities for cancer prevention

This publication has 10 references indexed in Scilit:

• Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
  The Lancet, 1998
• Prostatic Hyperplasia: An Unknown Feature of Acromegaly
  Journal of Clinical Endocrinology & Metabolism, 1998
• Childhood energy intake and adult mortality from cancer: the boyd orr cohort study
  BMJ, 1998
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
  Science, 1998
• Growth hormone treatment induces mammary gland hyperplasia in aging primates
  Nature Medicine, 1997
• Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner
  Journal of Biological Chemistry, 1997
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism
  Journal of Biological Chemistry, 1997
• Birthweight as a risk factor for breast cancer
  The Lancet, 1996
• Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors
  Physiological Reviews, 1996
• Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients
  International Journal of Cancer, 1996